Affiliation:
1. Department of Nuclear Technology, Nagaoka University of Technology, Nagaoka, Niigata 940-2188, Japan
Abstract
Technetium-99m(99mTc) is used worldwide in 85% of nuclear medicine diagnostic imaging procedures. We developed porous MoO2 pellets as an alternative to reactor-based targets in an (n,γ) reaction for producing Technetium-99m (99mTc) in nuclear medicine. The pellets, formed through a manufacturing process involving mixing, sintering, eluting, and drying, offer advantages such as selective dissolution and improved yield. This research offers a potential solution for stable 99mTc production, focusing on porous molybdenum dioxide (MoO2) as a target material due to its insolubility in water. Using potassium molybdate (K2MoO4) as a pore former, we developed porous MoO2 pellets that facilitate efficient technetium extraction and target recycling. This approach offers control over pore formation and shows promise in addressing supply challenges and enhancing 99mTc production.
Subject
General Materials Science
Reference21 articles.
1. OECD, Nuclear Energy Agency (2019). The Supply of Medical Isotopes, OECD, Nuclear Energy Agency.
2. Verbeek, P. (2008). Report on Molybdenum-99 Production for Nuclear Medicine 2010–2020, Nuclear Research and Consultancy Group. AIPES Report.
3. High purity materials as targets for radioisotope production: Needs and challenges;Shivarudrappa;Bull. Mater. Sci.,2005
4. The medical testing crisis;Nature,2013
5. Molybdenum-99 production pathways and the sorbents for 99Mo/99mTc generator systems using (n, γ) 99Mo: A review;Hasan;SN Appl. Sci.,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献